Omalizumab biosimilar(PharmAbcine)

N/A

Report date: 2025/03/07 17:33:46

Base Information

Drug NameOmalizumab biosimilar(PharmAbcine)
Drug Alias NamePMC-904
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Biosimilar
Mechanisms of ActionImmunosuppressantsImmunoglobulin E inhibitors
TargetsImmunoglobulin E
Therapy Area/IndicationsUrticariaAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharmabcine
China Registration ClassN/A

Develop Information

Active CompaniesPharmabcine
Inactive CompaniesN/A
Active IndicationsUrticariaAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A